BioCentury
ARTICLE | Company News

Atritech, Boston Scientific deal

March 14, 2011 7:00 AM UTC

Boston Scientific completed its previously announced acquisition of cardiovascular device company Atritech for $100 million in cash up front, plus up to $275 million in regulatory and revenue mileston...